$DCH

DCH Maintained by UBS -- Price Target Lowered to $8.00

UBS maintained a 'Buy' rating on Dauch Corp (DCH) but lowered its price target to $8.00 from $9.00. DCH's GF Value™ is $5.92, suggesting a 2.2% undervaluation. The company has a GF Score™ of 81/100, with strong growth and momentum but weaker financial strength. Eight gurus hold DCH, with mixed recent activity.

Original reporting
Published Oct 7, 2026, 9:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 10:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$DCH
Neutral
medium confidence
Mentioned
$DCH
Relevance
6/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$DCHNeutralLow
01

Why it matters

The price‑target cut reflects UBS's cautious outlook amid recent market conditions, potentially prompting short‑term traders to reassess positions.

02

Market read

A modest analyst downgrade for a small‑cap industrial stock; limited trading impact beyond DCH.

03

What to watch

The analyst note does not address DCH's unprofitability or cash‑flow constraints, which could be material for longer‑term investors.

Relevance 6/10Novelty 5/10Timing: today

Background

Dauch Corp (DCH) is a Tier‑1 automotive supplier with a market cap of about $1.38 billion, currently trading around $5.79.

Company-level read

Ticker impact

$DCHNeutralMedium confidence
Context

UBS maintained a Buy rating on Dauch Corp while lowering its price target from $9.00 to $8.00, a fresh analyst downgrade signal.

Expected impact

likely slight downward pressure as investors price in the lower target.

Evidence & confidence

Analyst price‑target cuts typically lead to short‑term price adjustments, but the rating remains Buy, limiting the magnitude.

Market effects

The downgrade may prompt a modest re‑rating of other Tier‑1 automotive suppliers in the Vehicles & Parts sector.

Limited to U.S. investors focused on small‑cap industrial stocks.

Minimal; the news is company‑specific without broader macro implications.

Counterpoint

Despite the lower target, the Buy rating and strong growth scores could support a rebound if earnings improve.

Key entities

  • UBS

    Maintained Buy rating, lowered price target to $8.00.

  • Dauch Corp

    Automotive driveline and metal‑forming supplier.

Related articles

$DCHMed

Why is Dauch stock gaining today?

Dauch (DCH) stock rose 1.4% in pre-market trading after announcing a planned CFO transition. Nathan Iles will become CFO on December 1, 2026, replacing Christopher May, who will take a new role. The orderly succession is seen as a positive sign by investors, with the stock trading below its 52-week high of $9.25.

$DCHMed

Dauch Corporation’s (DCH) Costly Path To A Bigger Payoff

Dauch Corporation (NYSE:DCH) reported Q2 sales of about $3B and adjusted EBITDA of $389.6M (13.2% of sales), citing integration progress after its Dowlais acquisition. It raised full-year guidance: sales $10.6B-$10.8B, adjusted EBITDA $1.36B-$1.425B, adjusted FCF $260M-$325M. Net interest expense rose to $82.6M and GAAP net income fell to $1M.

$DCHMedAI 8/10

Dauch (DCH) Q2 2026 Earnings Call Transcript

Dauch Corporation (DCH) held its Q2 2026 earnings call, reporting sales of $2.96B versus $1.54B prior year, boosted by $1.45B from the Dowlais acquisition. Adjusted EBITDA was $389.6M (13.2%) and adjusted free cash flow $148.4M. Full-year guidance: sales $10.6B-$10.8B and adjusted EBITDA $1.36B-$1.425B. Net leverage was 2.6x.

$DCHMedAI 8/10

American Axle & Manufacturing Q2 Earnings Call Highlights

American Axle & Manufacturing (DCH) reported Q2 adjusted EBITDA of $389.6M (13.2% of sales). It recorded $15M in quarterly synergy benefits and targets $100M+ by year-end. Cash from operations was $107.5M and adjusted free cash flow $148.4M. Full-year guidance raised: sales $10.6B-$10.8B and adjusted EBITDA $1.36B-$1.425B.